Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Approved FDF
Sponsor : Lannett Company, Inc.
Deal Size : Undisclosed
Deal Type : Agreement
LANNETT Expands Respiratory Pipeline, Signs Exclusive Commercialization
Details :
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
July 29, 2021
Lead Product(s) : Tiotropium Bromide
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Approved FDF
Sponsor : Lannett Company, Inc.
Deal Size : Undisclosed
Deal Type : Agreement